[go: up one dir, main page]

CN114480277B - A kind of method and medium for stimulating dendritic cell maturation - Google Patents

A kind of method and medium for stimulating dendritic cell maturation Download PDF

Info

Publication number
CN114480277B
CN114480277B CN202210338128.3A CN202210338128A CN114480277B CN 114480277 B CN114480277 B CN 114480277B CN 202210338128 A CN202210338128 A CN 202210338128A CN 114480277 B CN114480277 B CN 114480277B
Authority
CN
China
Prior art keywords
cells
maturation
stimulating
medium
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210338128.3A
Other languages
Chinese (zh)
Other versions
CN114480277A (en
Inventor
时红波
张兴娜
刘超楠
卢旺
时红林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Institute Of Liver Diseases
Beijing Youan Hospital
Original Assignee
Beijing Youan Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Youan Hospital filed Critical Beijing Youan Hospital
Priority to CN202210338128.3A priority Critical patent/CN114480277B/en
Publication of CN114480277A publication Critical patent/CN114480277A/en
Application granted granted Critical
Publication of CN114480277B publication Critical patent/CN114480277B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0639Dendritic cells, e.g. Langherhans cells in the epidermis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明公开了一种刺激树突状细胞成熟的方法,在未成熟树突状细胞刺激成熟过程中加入无水乙醇进行刺激成熟培养。上述刺激树突状细胞成熟的方法,具体包括如下步骤:(1)将未成熟的树突状细胞铺于培养皿中,加入培养基培养,待其贴壁后,换液;(2)在步骤(1)得到的细胞中再加入含有无水乙醇的培养基刺激培养至少24小时,收集细胞及上清。本发明经实验证实可有效促进DC细胞成熟,而且刺激成熟的效果优于现有技术中的LPS和TNF‑α组,并且可以有效上调细胞表面抗原CD54、CD80、CD86及抗原呈递分子MHC II表达。

Figure 202210338128

The invention discloses a method for stimulating the maturation of dendritic cells. In the process of stimulating and maturing immature dendritic cells, anhydrous ethanol is added to stimulate the maturation culture. The above-mentioned method for stimulating the maturation of dendritic cells specifically includes the following steps: (1) spreading immature dendritic cells in a culture dish, adding a medium for culture, and changing the medium after they adhere to the wall; (2) placing the immature dendritic cells in a culture dish A medium containing absolute ethanol is added to the cells obtained in step (1) to stimulate culture for at least 24 hours, and the cells and supernatant are collected. The invention has been proved by experiments that it can effectively promote the maturation of DC cells, and the effect of stimulating maturation is better than that of the LPS and TNF-α groups in the prior art, and can effectively upregulate the expression of cell surface antigens CD54, CD80, CD86 and antigen presentation molecule MHC II .

Figure 202210338128

Description

一种刺激树突状细胞成熟的方法及培养基A kind of method and medium for stimulating dendritic cell maturation

技术领域technical field

本发明涉及一种树突状细胞刺激成熟的方法及刺激成熟用培养基,属于生物技术领域。The invention relates to a method for stimulating maturation of dendritic cells and a culture medium for stimulating maturation, belonging to the field of biotechnology.

背景技术Background technique

树突状细胞 (dendritic cells,简写为DCs) 是目前发现的功能最强大的能激活初始型T淋巴细胞的抗原呈递细胞(antigen-presenting cell, 简写为APC)。DC2.4细胞是通过转染癌基因v-myc和v-raf的C57BL/6小鼠骨髓细胞而建立的永生化细胞系,具有很强的吞噬功能,是用于DC研究的一种标准的未成熟细胞系。通过化学试剂刺激,可以改变细胞表面抗原的表达,促进其成熟。Dendritic cells (DCs) are the most powerful antigen-presenting cells (APCs) that can activate naive T lymphocytes. DC2.4 cells are immortalized cell lines established by transfecting C57BL/6 mouse bone marrow cells with oncogenes v-myc and v-raf. They have strong phagocytic function and are a standard for DC research. immature cell lines. Stimulation by chemical agents can change the expression of cell surface antigens and promote their maturation.

树突状细胞疫苗(dendritic cell vaccine,DC疫苗)是指负载了相关抗原的成熟DC,是近年发展起来的最有潜力的新型免疫治疗方法之一。DC疫苗对某些肿瘤的临床治疗已取得显著疗效,而由HBV表面抗原(HBsAg)负载的DC疫苗能在健康志愿者和慢性乙型肝炎(CHB)病人体内诱导出抗HBV特异性免疫反应。因此,发展HBV特异性DC疫苗在治疗CHB的临床应用中具有重要意义,建立DC疫苗制备的质量控制与评价体系,是HBV特异性DC疫苗临床试验的前提。Dendritic cell vaccine (DC vaccine) refers to mature DCs loaded with relevant antigens, and is one of the most promising new immunotherapy methods developed in recent years. The clinical treatment of certain tumors with DC vaccines has achieved significant efficacy, and DC vaccines loaded with HBV surface antigen (HBsAg) can induce anti-HBV-specific immune responses in healthy volunteers and chronic hepatitis B (CHB) patients. Therefore, the development of HBV-specific DC vaccine is of great significance in the clinical application of the treatment of CHB, and the establishment of a quality control and evaluation system for the preparation of DC vaccine is the premise of HBV-specific DC vaccine clinical trials.

DC细胞体外刺激成熟的方法没有统一标准,目前现有技术主要采用TNF-α或LPS(脂多糖)来刺激DC成熟。LPS和TNF-α刺激DC的成熟度效果不佳。主要技术问题在于:它们可在一定程度上刺激DC成熟, 但仍无法得到与临床所需疗效相匹配的高度成熟DC。有研究表明,TNF-α催熟的DC细胞在功能上有缺陷,在细胞成熟后几乎不能分泌IL-12。DC诱导免疫激活的前提是需要足够数量的高度成熟DC,及表达足够量的抗原肽和分泌大量细胞因子, 才能有效地诱导免疫应答, 发挥临床疗效。LPS刺激DC成熟还有个难以克服的操作问题,即生产LPS厂家不同造成LPS纯度不同,所以刺激DC成熟使用的LPS浓度也不同,造成操作上的繁琐及结果的不确定。另外LPS保存条件比较严格,4℃仅能存放一个月,想要长期存放需-20℃存放,但应避免反复冻融,增加了操作的复杂性。There is no uniform standard for the method of stimulating the maturation of DC cells in vitro. At present, the existing technology mainly uses TNF-α or LPS (lipopolysaccharide) to stimulate the maturation of DCs. LPS and TNF-α stimulated the maturation of DCs poorly. The main technical problem is that they can stimulate DC maturation to a certain extent, but still cannot obtain highly mature DCs that match the clinically desired efficacy. Studies have shown that TNF-α-matured DC cells are functionally defective and can hardly secrete IL-12 after cell maturation. The premise of DC-induced immune activation is that a sufficient number of highly mature DCs, expressing a sufficient amount of antigenic peptides and secreting a large number of cytokines are required to effectively induce an immune response and exert clinical efficacy. LPS stimulation of DC maturation also has an insurmountable operational problem, that is, different LPS manufacturers result in different LPS purity, so the LPS concentration used to stimulate DC maturation is also different, resulting in cumbersome operations and uncertain results. In addition, the storage conditions of LPS are relatively strict. It can only be stored at 4 °C for one month. If you want to store it for a long time, it needs to be stored at -20 °C, but repeated freezing and thawing should be avoided, which increases the complexity of the operation.

发明内容SUMMARY OF THE INVENTION

本发明所要解决的首要技术问题在于提供一种刺激树突状细胞成熟的方法。The primary technical problem to be solved by the present invention is to provide a method for stimulating the maturation of dendritic cells.

本发明所要解决的另一技术问题在于提供一种刺激树突状细胞成熟的培养基。Another technical problem to be solved by the present invention is to provide a medium for stimulating the maturation of dendritic cells.

为了实现上述目的,本发明采用如下的技术方案:In order to achieve the above object, the present invention adopts the following technical scheme:

根据本发明实施例的第一方面,提供一种刺激树突状细胞成熟的方法,在未成熟树突状细胞刺激成熟过程中加入催熟剂无水乙醇进行刺激成熟培养,所述方法步骤如下:According to a first aspect of the embodiments of the present invention, a method for stimulating the maturation of dendritic cells is provided. In the process of stimulating and maturing immature dendritic cells, a ripening agent absolute ethanol is added to stimulate the maturation culture. The method steps are as follows :

(1)将未成熟的树突状细胞铺于培养皿中,加入培养基培养,待其贴壁后,换液;(1) Spread the immature dendritic cells in a petri dish, add the medium for culture, and change the medium after they adhere to the wall;

(2)将步骤(1)得到的细胞在含有催熟剂无水乙醇的培养基中刺激培养中至少24小时,收集细胞及上清。(2) The cells obtained in step (1) are stimulated and cultured in a medium containing a ripening agent absolute ethanol for at least 24 hours, and the cells and supernatant are collected.

其中较优地,所述无水乙醇的添加浓度为400 mmol/L~800 mmol/L。Preferably, the added concentration of the absolute ethanol is 400 mmol/L to 800 mmol/L.

其中较优地,所述培养基为1640完全培养基。Preferably, the medium is 1640 complete medium.

根据本发明实施例的第二方面,提供一种刺激树突状细胞成熟的方法,包括如下步骤:According to a second aspect of the embodiments of the present invention, there is provided a method for stimulating the maturation of dendritic cells, comprising the following steps:

(1) 获取树突状细胞前体单个核细胞PBMC,在第一培养基培养下获得未成熟树突状细胞;(1) Obtain dendritic cell precursor mononuclear cell PBMC, and obtain immature dendritic cells in the first medium;

(2) 将在步骤(1)得到的细胞在第二培养基中促成熟培养,培养时间至少24小时,得到树突状细胞;(2) promoting the maturation of the cells obtained in step (1) in the second medium for at least 24 hours to obtain dendritic cells;

所述第一培养基为内含GM-CSF和IL-4的培养基,所述第二培养基为在第一培养基中加入催熟剂无水乙醇。The first medium is a medium containing GM-CSF and IL-4, and the second medium is a ripening agent absolute ethanol added to the first medium.

其中较优地,所述无水乙醇的添加浓度为400 mmol/L~800 mmol/L。Preferably, the added concentration of the absolute ethanol is 400 mmol/L to 800 mmol/L.

其中较优地,所述第一培养基为无血清的AIM-V培养基。Preferably, the first medium is serum-free AIM-V medium.

其中较优地,所述GM-CSF的终浓度为800~1000U/ml,IL-4的终浓度为800~1000U/ml。Preferably, the final concentration of GM-CSF is 800-1000 U/ml, and the final concentration of IL-4 is 800-1000 U/ml.

根据本发明实施例的第三方面,提供一种刺激树突状细胞成熟的培养基,所述培养基为在树突状细胞培养基中添加无水乙醇,所述无水乙醇的添加浓度为400 mmol/L~800 mmol/L。According to a third aspect of the embodiments of the present invention, there is provided a culture medium for stimulating dendritic cell maturation, the culture medium is adding absolute ethanol to the dendritic cell culture medium, and the concentration of the absolute ethanol added is: 400 mmol/L~800 mmol/L.

其中较优地,所述无水乙醇的工作浓度为400 mmol/L~800 mmol/L。Preferably, the working concentration of the absolute ethanol is 400 mmol/L~800 mmol/L.

本发明的有益效果如下:The beneficial effects of the present invention are as follows:

本发明解决了现有技术中催熟剂催熟效果不佳,催熟剂浓度不统一,操作难度大等问题。本发明提出利用无水乙醇作为催熟剂刺激树突状细胞成熟的方法,经实验证实可有效促进DC细胞成熟,而且刺激成熟的效果优于现有技术中的LPS和TNF-α组,并可以有效上调细胞表面抗原CD54、CD80、CD86及抗原呈递分子MHC II表达。另一方面,本领域技术人员惯用无水乙醇进行细胞损伤造模,本发明克服了本领域技术人员的习惯思维提出的。无水乙醇作为催熟剂的另一优势在于,各厂家售卖的无水乙醇标准一致,非常便于树突状细胞促成熟培养操作,购买方便且成本较低。The invention solves the problems in the prior art that the ripening effect of the ripening agent is not good, the concentration of the ripening agent is not uniform, and the operation is difficult. The invention proposes a method for stimulating the maturation of dendritic cells by using anhydrous ethanol as a ripening agent, which is proved by experiments to effectively promote the maturation of DC cells, and the effect of stimulating maturation is better than that of the LPS and TNF-α groups in the prior art, and It can effectively up-regulate the expression of cell surface antigens CD54, CD80, CD86 and antigen-presenting molecule MHC II. On the other hand, those skilled in the art routinely use absolute ethanol for cell damage modeling, and the present invention overcomes the habitual thinking of those skilled in the art. Another advantage of anhydrous ethanol as a ripening agent is that the standard of anhydrous ethanol sold by various manufacturers is consistent, which is very convenient for dendritic cell maturation-promoting culture operations, convenient to purchase and low cost.

附图说明Description of drawings

图1A为200mmol/L无水乙醇催熟效果图;Fig. 1A is 200mmol/L absolute ethanol ripening effect figure;

图1B为400mmol/L无水乙醇催熟效果图;Fig. 1B is 400mmol/L absolute ethanol ripening effect diagram;

图1C为600mmol/L无水乙醇催熟效果图;Fig. 1C is 600mmol/L absolute ethanol ripening effect figure;

图1D为800mmol/L无水乙醇催熟效果图;Fig. 1D is the effect diagram of 800mmol/L anhydrous ethanol ripening;

图1E 为20ug/ml LPS催熟效果图;Figure 1E is the effect of 20ug/ml LPS ripening;

图1F 1000U/ml TNF-α催熟效果图;Figure 1F 1000U/ml TNF-α ripening effect diagram;

图2A为正常DC2.4细胞图;Figure 2A is a diagram of normal DC2.4 cells;

图2B为600mmol/L无水乙醇刺激24h后细胞图;Figure 2B is a cell diagram after 24h stimulation with 600mmol/L absolute ethanol;

图2C为800mmol/L无水乙醇刺激24h后细胞图;Figure 2C is a cell diagram after 24h stimulation with 800mmol/L absolute ethanol;

图2D为1200mmol/L无水乙醇刺激24h后细胞图;Figure 2D is a cell diagram after 1200mmol/L absolute ethanol stimulation for 24h;

图3A未经无水乙醇刺激的DC2.4细胞CD86表达量图;Figure 3A is a graph of CD86 expression in DC2.4 cells not stimulated by absolute ethanol;

图3B经无水乙醇(600mmol/l)刺激的DC2.4细胞CD86表达量图;Figure 3B shows the expression of CD86 in DC2.4 cells stimulated by absolute ethanol (600mmol/l);

图3C未经无水乙醇刺激的DC2.4细胞外泌体图;Figure 3C is a picture of DC2.4 cell exosomes without anhydrous ethanol stimulation;

图3D经无水乙醇(600mmol/l)刺激的DC2.4细胞外泌体图;Figure 3D Exosomes of DC2.4 cells stimulated by absolute ethanol (600mmol/l);

图4A为MoDC-CD54表达量图;Figure 4A is a graph of MoDC-CD54 expression;

图4B为MoDC-CD80表达量图;Figure 4B is a graph of MoDC-CD80 expression;

图4C为MoDC-CD86表达量图;Figure 4C is a graph of MoDC-CD86 expression;

图5A为未刺激组第8天细胞图;Figure 5A is a cell diagram of the unstimulated group on the 8th day;

图5B为LPS刺激组第8天细胞图;Figure 5B is a cell diagram of the LPS stimulation group on the 8th day;

图5C为TNF-α刺激组第8天细胞图;Figure 5C is the cell diagram of the TNF-α stimulation group on the 8th day;

图5D为无水乙醇组第8天细胞图。Fig. 5D is the cell chart on the 8th day in the absolute ethanol group.

具体实施方式Detailed ways

为了使本领域技术人员对本发明有清楚的了解,下面利用具体实施例进行详细说明。各个实施例中所使用的方法如无特殊说明,均为常规方法。In order for those skilled in the art to have a clear understanding of the present invention, specific embodiments are used for detailed description below. The methods used in each embodiment are conventional methods unless otherwise specified.

下述实施例中使用的材料及来源如下:The materials and sources used in the following examples are as follows:

1640培养基(Gibco);胎牛血清(Gibco); 无血清AIM-V培养基(Gibco );无水乙醇(北京东方事博);DC2.4(丰晖生物);M-MHC II(BD);M-CD86(BD);CD63(BD);H-CD54(BD);H-CD80(BD);H-CD86(BD);粒细胞一巨噬细胞集落刺激因子(GM-CSF )( PeproTech )肿瘤坏死因子一(TNF-a )(美国PeproTech );白细胞介素—4(IL-4 )( PeproTech )。1640 medium (Gibco); fetal bovine serum (Gibco); serum-free AIM-V medium (Gibco); absolute ethanol (Beijing Oriental Shibo); DC2.4 (Fenghui Bio); M-MHC II (BD ); M-CD86 (BD); CD63 (BD); H-CD54 (BD); H-CD80 (BD); H-CD86 (BD); granulocyte-macrophage colony stimulating factor (GM-CSF ) ( PeproTech) tumor necrosis factor-a (TNF-a) (PeproTech, USA); interleukin-4 (IL-4) (PeproTech).

实施例1 不同浓度无水乙醇对DC2.4细胞促成熟效果对比Example 1 Comparison of maturation-promoting effects of different concentrations of anhydrous ethanol on DC2.4 cells

DC作为适应性免疫应答的起始者, 是功能最强的专职抗原提呈细胞,可识别肿瘤细胞表面的抗原,增强肿瘤细胞的免疫原性而有效避免免疫逃逸,同时,分化为成熟DC后表现出高效的抗原提呈功能和诱导初始T细胞活化参与免疫应答的功能。无水乙醇在本领域内一般用于制作肝损伤模型,无水乙醇对细胞有一定负面作用,我们设置了浓度梯度比较,发现无水乙醇在特定浓度状态下可以对DC细胞起到很好的催熟功效,且无水乙醇浓度很容易达到一致,购买方便,成本低廉,便于保存。As the initiator of adaptive immune response, DCs are the most powerful professional antigen-presenting cells, which can recognize antigens on the surface of tumor cells, enhance the immunogenicity of tumor cells and effectively avoid immune escape. It exhibits efficient antigen presentation function and the function of inducing naive T cell activation to participate in immune response. Anhydrous ethanol is generally used to make liver injury models in this field. Anhydrous ethanol has a certain negative effect on cells. We set up a concentration gradient comparison and found that anhydrous ethanol can play a good role in DC cells at a specific concentration. Ripening effect, and the concentration of anhydrous ethanol is easy to achieve the same, easy to buy, low cost, easy to store.

材料来源:Source of material:

1. 实验方法及分组1. Experimental method and grouping

(1)实验方法:将DC2.4细胞铺到10cm培养皿中,加入1640完全培养基(含10%胎牛血清的RP-MI 1640培养液),待其贴壁后,换液;(1) Experimental method: Spread DC2.4 cells into a 10cm petri dish, add 1640 complete medium (RP-MI 1640 medium containing 10% fetal bovine serum), and change the medium after they adhere to the wall;

(2)将培养后的细胞分为6组,在6组培养基中分别加入不同浓度无水乙醇、LPS及TNF-α;无水乙醇的浓度分别为200mmol/L、400mmol/L、600mmol/L及800mmol/L,LPS为20ug/ml、TNF-α为1000U/ml;(2) The cultured cells were divided into 6 groups, and different concentrations of absolute ethanol, LPS and TNF-α were added to the medium of the 6 groups; the concentrations of absolute ethanol were 200mmol/L, 400mmol/L, 600mmol/L, respectively. L and 800mmol/L, LPS is 20ug/ml, TNF-α is 1000U/ml;

(3) 刺激24h,分别收集细胞。(3) After stimulation for 24h, cells were collected separately.

(4)将6组细胞分别离心800r/min,5min,用100ul重悬细胞,加入MHC II抗体5ul,置于冰上,避光孵育30min,加入1ml PBS洗去多余抗体,调节细胞浓度为1×106/ml-1×107/ml,取500ul至EP管,标记,用量化成像分析流式细胞仪上机。(4) Centrifuge the 6 groups of cells at 800 r/min for 5 min, resuspend the cells in 100 ul, add 5 ul of MHC II antibody, place on ice, incubate in the dark for 30 min, add 1 ml of PBS to wash off excess antibodies, and adjust the cell concentration to 1 ×10 6 /ml-1 × 10 7 /ml, take 500ul to EP tube, label, use quantitative imaging analysis flow cytometer on the machine.

2. 实验结果2. Experimental results

如图1A~图1F所示,流式细胞仪检测结果表明200mmol/L无水乙醇组DC2.4细胞表面MHC II分子的表达水平为1.52%,400mmol/L无水乙醇组DC2.4细胞表面MHC II分子的表达水平为2.38%,600mmol/L无水乙醇组DC2.4细胞表面MHC II分子的表达水平为25.02%,800mmol/L无水乙醇组DC2.4细胞表面MHC II分子的表达水平为13.53%, 20ug/ml LPS 组DC2.4细胞表面MHC II分子的表达水平为2.36%,1000U/mlTNF-α组DC2.4细胞表面MHC II分子的表达水平为2.11%。As shown in Figure 1A to Figure 1F, the results of flow cytometry showed that the expression level of MHC II molecules on the surface of DC2.4 cells in the 200 mmol/L absolute ethanol group was 1.52%, and that on the surface of DC2.4 cells in the 400 mmol/L absolute ethanol group was 1.52%. The expression level of MHC II molecules was 2.38%, the expression level of MHC II molecules on the surface of DC2.4 cells in 600mmol/L absolute ethanol group was 25.02%, and the expression level of MHC II molecules on the surface of DC2.4 cells in 800 mmol/L absolute ethanol group The expression level of MHC II molecules on the surface of DC2.4 cells in 20ug/ml LPS group was 2.36%, and the expression level of MHC II molecules on the surface of DC2.4 cells in 1000U/ml TNF-α group was 2.11%.

以上数据表明LPS、TNF-α刺激DC2.4 成熟效果不佳。400-800mmol/L无水乙醇组MHC II分子的表达水平均较高,其中600mmol/L无水乙醇组MHC II分子的表达水平最高,说明无水乙醇刺激DC2.4最佳浓度为400~800mmol/l。The above data indicated that LPS and TNF-α had poor effect on stimulating DC2.4 maturation. The expression levels of MHC II molecules in the 400-800 mmol/L absolute ethanol group were higher, and the expression level of MHC II molecules in the 600 mmol/L absolute ethanol group was the highest, indicating that the optimal concentration of DC2.4 stimulated by absolute ethanol was 400-800 mmol /l.

如图2A~图2D所示,图2A为正常DC2.4细胞,图2B为600mmol/L无水乙醇刺激24h后,图2C为800mmol/L无水乙醇刺激24h后,图2D为1200mmol/L无水乙醇刺激24h后,由图可见,正常DC2.4细胞贴壁生长,呈上皮样,800mmol/L无水乙醇刺激后细胞与正常细胞无差异。通过光学显微镜观察到,当无水乙醇浓度为1200mmol/L时,大量细胞死亡回缩,呈悬浮状,说明该浓度已经对细胞造成极大的损害作用,不宜作为刺激DC2.4成熟的浓度范围。因此无水乙醇浓度在800mmol/L浓度以下对DC细胞是安全的可靠的刺激浓度。As shown in Figure 2A to Figure 2D, Figure 2A shows normal DC2.4 cells, Figure 2B shows 600 mmol/L absolute ethanol after stimulation for 24 hours, Figure 2C shows 800 mmol/L absolute ethanol stimulation for 24 hours, and Figure 2D shows 1200 mmol/L After 24h stimulation with absolute ethanol, it can be seen from the figure that normal DC2.4 cells grow adherently and are epithelial-like, and there is no difference between cells and normal cells after stimulation with 800 mmol/L absolute ethanol. It was observed by optical microscope that when the concentration of absolute ethanol was 1200mmol/L, a large number of cells died and retracted and became suspended, indicating that this concentration has caused great damage to cells and should not be used as a concentration range for stimulating DC2.4 maturation. . Therefore, the concentration of absolute ethanol below 800mmol/L is a safe and reliable stimulation concentration for DC cells.

实施例2 DC2.4细胞利用无水乙醇刺激及未利用无水乙醇刺激CD86表达量对比实验Example 2 Comparative experiment of CD86 expression in DC2.4 cells stimulated with absolute ethanol and not stimulated with absolute ethanol

1. 实验方法1. Experimental method

(1)将DC2.4细胞分两组(刺激组和未刺激组),铺到10cm培养皿中,加入1640完全培养基(含10%胎牛血清的RP-MI 1640培养液)。(1) Divide DC2.4 cells into two groups (stimulated group and unstimulated group), spread them into 10cm petri dishes, and add 1640 complete medium (RP-MI 1640 medium containing 10% fetal bovine serum).

(2)刺激组待其贴壁后,换液,加入1640完全培养基+600mmol/L无水乙醇(10ml:0.35ml),刺激24h,分别收集细胞和上清。(2) After the stimulation group adhered to the wall, the medium was changed, 1640 complete medium + 600 mmol/L absolute ethanol (10 ml: 0.35 ml) was added, and the cells were stimulated for 24 hours, and the cells and supernatant were collected respectively.

(3)收集未刺激组DC2.4细胞和上清。(3) Collect DC2.4 cells and supernatant in the unstimulated group.

(4)将两种细胞分别离心800r/min,5min,用100ul重悬细胞,加入CD86抗体5ul,置于冰上,避光孵育30min,加入1ml PBS洗去多余抗体,调节细胞浓度为1×106/ml-1×107/ml,取500ul至EP管,标记,用量化成像分析流式细胞仪上机。(4) Centrifuge the two types of cells at 800 r/min for 5 min, resuspend the cells in 100 ul, add 5 ul of CD86 antibody, place on ice, incubate in the dark for 30 min, add 1 ml of PBS to wash off excess antibody, and adjust the cell concentration to 1× 106/ml-1×107/ml, take 500ul to EP tube, label, and use quantitative imaging analysis flow cytometer on the machine.

(5)将收集的两种细胞上清(40ml)进行离心2000r/min,10min,去掉大的细胞碎片,取上清,10000r/min,30min,去掉残余的细胞碎片及细胞器等,取上清。使用超速离心机将上清继续离心,110000r/min,70min,弃掉上清,用管壁回流液体重悬,得到外泌体,加入CD63抗体10ul和CD86抗体5ul,置于冰上,避光孵育45min。加入PBS洗去多余抗体,再次使用超速离心机离心,110000r/min,70min,弃掉上清,用管壁回流液体重悬,移液至EP管,标记,用量化成像分析流式细胞仪上机。(5) Centrifuge the collected two cell supernatants (40ml) at 2000r/min for 10min, remove large cell debris, take the supernatant, 10000r/min, 30min, remove the residual cell debris and organelles, etc., take the supernatant . Use an ultracentrifuge to continue centrifuging the supernatant at 110,000 r/min for 70 min. Discard the supernatant and resuspend it with the backflow liquid from the tube wall to obtain exosomes. Add 10 ul of CD63 antibody and 5 ul of CD86 antibody, and place on ice to protect from light. Incubate for 45min. Add PBS to wash off excess antibodies, centrifuge again with an ultracentrifuge at 110,000 r/min, 70 min, discard the supernatant, resuspend with the backflow liquid from the tube wall, pipet to an EP tube, label, and use quantitative imaging to analyze the flow cytometer machine.

2. 实验结果2. Experimental results

如图3A-3D及表1所示。As shown in Figures 3A-3D and Table 1.

表1Table 1

DC2.4DC2.4 DC2.4外泌体DC2.4 exosomes 未刺激Not stimulated 7.69%7.69% 0.09%0.09% 刺激后after stimulation 46.74%46.74% 3.43%3.43%

3. 结论3. Conclusion

如图3A~图3D所示,图3A为未刺激DC2.4细胞的流式结果图,CD86表达水平为7.69%,图3B为无水乙醇刺激后DC2.4细胞的流式结果图,CD86表达水平为46.74%;图3C为未刺激DC2.4细胞上清外泌体的流式结果图,CD86表达水平为0.09%,图3D为无水乙醇刺激后DC2.4细胞上清外泌体的流式结果图,CD86表达水平为3.43%。(CD63为外泌体标记物,故外泌体CD86的表达水平看CD63和CD86的双阳比例)DC2.4细胞经无水乙醇刺激后,细胞表面抗原CD86表达量明显增多,DC2.4分泌的外泌体中CD86表达量也明显增多,说明本发明方法可以上调DC2.4细胞表面抗原的表达,促进DC2.4成熟。As shown in Figure 3A to Figure 3D, Figure 3A is the flow chart of unstimulated DC2.4 cells, the CD86 expression level is 7.69%, Figure 3B is the flow chart of DC2.4 cells stimulated by absolute ethanol, CD86 The expression level is 46.74%; Figure 3C shows the flow cytometry results of the supernatant exosomes of unstimulated DC2.4 cells, the CD86 expression level is 0.09%, and Figure 3D shows the supernatant exosomes of DC2.4 cells stimulated with absolute ethanol The flow chart of the results showed that the CD86 expression level was 3.43%. (CD63 is an exosome marker, so the expression level of exosome CD86 depends on the double-positive ratio of CD63 and CD86.) After DC2.4 cells were stimulated by absolute ethanol, the expression of cell surface antigen CD86 increased significantly, and DC2.4 secreted The expression of CD86 in exosomes also increased significantly, indicating that the method of the present invention can up-regulate the expression of DC2.4 cell surface antigen and promote the maturation of DC2.4.

实施例3 慢乙肝病人DC催熟实验Example 3 DC ripening experiment in patients with chronic hepatitis B

1. 实验方法1. Experimental method

(1)细胞培养:(1) Cell culture:

0d: PBMC的分离:采集北京佑安医院人工肝慢乙肝病人外周血,分离出PBMC,用PBS洗涤去除细胞碎片和血小板。以无血清AIM-V培养液悬浮细胞,计数,调整细胞浓度至5×106/ml,铺于6孔板中,每孔2-3ml AIM-V培养液,37℃,5%的CO2孵箱中温育1-2h,使单核细胞贴壁。当孵育结束时,吸出每个培养孔内的液体和未贴壁细胞,在每孔中加入AIM-V培养基1ml,内含终浓度为800U/ml的GM-CSF和1000U/ml的IL-4,置37℃,5%的CO2孵箱中培养2d。0d: Separation of PBMCs: The peripheral blood of patients with artificial hepatitis B in Beijing You'an Hospital was collected, PBMCs were separated, and cell debris and platelets were removed by washing with PBS. Suspend the cells in serum-free AIM-V medium, count, adjust the cell concentration to 5×10 6 /ml, and plate them in a 6-well plate with 2-3ml of AIM-V medium per well, 37°C, 5% CO 2 Incubate for 1-2h in the incubator to make monocytes adherent. When the incubation is over, aspirate the liquid and non-adherent cells in each culture well, and add 1 ml of AIM-V medium to each well, which contains GM-CSF at a final concentration of 800 U/ml and IL-1000 U/ml. 4. Incubate for 2 days in a 37°C, 5% CO 2 incubator.

2d:倒置显微镜下观察细胞,全量换液,置孵箱中继续培养。2d: Observe the cells under an inverted microscope, change the medium in full, and continue culturing in an incubator.

5d:倒置显微镜下观察细胞,半量换液,置孵箱中继续培养。5d: Observe the cells under an inverted microscope, change half of the medium, and continue to culture in an incubator.

6d:倒置显微镜下观察细胞,进行分组,分别为空白对照(unstim);TNF-a组:加入TNF-a (1000U/ml );无水乙醇组:加入无水乙醇(600mmol/l)作为促成熟因子,继续培养1d。(均为终浓度)6d: Observe the cells under an inverted microscope and group them into blank control (unstim); TNF-a group: add TNF-a (1000U/ml); absolute ethanol group: add anhydrous ethanol (600mmol/l) as a booster. Mature factor, continue to culture for 1 d. (all final concentrations)

8d:倒置显微镜下观察各组细胞,收集每孔的悬浮细胞和疏松的贴壁细胞,取10ul测定MoDC细胞存活比例,取各组细胞悬液,离心,用于检测MoDC表型。8d: Observe the cells of each group under an inverted microscope, collect the suspended cells and loose adherent cells in each well, take 10ul of the cells to determine the survival ratio of MoDC cells, take the cell suspensions of each group, and centrifuge them to detect the phenotype of MoDC.

(2)流式细胞仪检测MoDC表面分子表达(2) Flow cytometry to detect the expression of MoDC surface molecules

未成熟与成熟的MoDC洗涤后分别用CD54,CD80, CD86单抗5ul室温避光孵育20min,加入1mlPBS洗去多余抗体,标记,用FACS在Cellquest下收获并分析。The immature and mature MoDC were washed with CD54, CD80, and CD86 monoclonal antibodies for 20 min at room temperature in the dark, and 1 ml of PBS was added to wash off excess antibodies, labeled, harvested and analyzed by FACS under Cellquest.

2. 实验结果2. Experimental results

如图4A~图4C所示,MoDC空白组、TNF-a组、无水乙醇刺激组CD54平均荧光强度分别为407、418、851;MoDC空白组、TNF-a组、无水乙醇刺激组CD80平均荧光强度分别为26、24.9、33.6;MoDC空白组、TNF-a组、无水乙醇刺激组CD86平均荧光强度分别为5.19、9.53、28.8。As shown in Figure 4A to Figure 4C, the mean fluorescence intensities of CD54 in the MoDC blank group, TNF-a group, and absolute ethanol stimulation group were 407, 418, and 851, respectively; the CD80 in the MoDC blank group, TNF-a group, and absolute ethanol stimulation group The mean fluorescence intensities were 26, 24.9, and 33.6, respectively; the mean fluorescence intensities of CD86 in the MoDC blank group, TNF-a group, and absolute ethanol stimulation group were 5.19, 9.53, and 28.8, respectively.

3. 结论3. Conclusion

流式结果显示,MoDC经无水乙醇刺激后,细胞表面分子CD54、CD80、CD86表达量明显高于空白对照组及TNF-a组。说明无水乙醇可以有效刺激MoDC成熟及促进其表面分子的表达。Flow cytometry results showed that after MoDC was stimulated with absolute ethanol, the expression levels of cell surface molecules CD54, CD80 and CD86 were significantly higher than those in blank control group and TNF-a group. It shows that absolute ethanol can effectively stimulate the maturation of MoDC and promote the expression of its surface molecules.

实施例4电镜下观察催熟细胞状态Example 4 Observation of ripening cell state under electron microscope

1.实验方法:PBMC培养到第6天进行分组,分为未刺激组,LPS组,TNF-a组和无水乙醇组(PBMC培养方法同上面实施例3)。第1天,第3天,第8天用光学显微镜拍摄照片。1. Experimental method: PBMCs were cultured to the 6th day for grouping and divided into unstimulated group, LPS group, TNF-a group and absolute ethanol group (the PBMC culture method was the same as in Example 3 above). Photographs were taken with a light microscope on day 1, day 3, and day 8.

2.实验结论:如图5A~图5D所示,为刺激第8天细胞图,通过光学显微镜观察,发现成熟树突状细胞与未成熟细胞比较,体积变大,有多个突起。无水乙醇组细胞与其它对照组比较, 成熟细胞数量明显增多, 而且细胞形态大小均一,说明无水乙醇的催熟功能相比其他组更好。2. Experimental conclusion: As shown in Fig. 5A to Fig. 5D, in order to stimulate the cells on the 8th day, through optical microscope observation, it is found that the mature dendritic cells are larger in size and have multiple protrusions compared with the immature cells. Compared with the other control groups, the number of mature cells in the absolute ethanol group increased significantly, and the cell shape and size were uniform, indicating that the ripening function of absolute ethanol was better than other groups.

Claims (6)

1. A method for stimulating dendritic cell maturation is characterized in that absolute ethyl alcohol is added in the process of stimulating the maturation of immature dendritic cells to stimulate maturation culture, and the method comprises the following steps:
(1) laying immature dendritic cells in a culture dish, adding a culture medium for culturing, and changing the culture medium after the cells adhere to the wall;
(2) adding a culture medium containing absolute ethyl alcohol into the cells obtained in the step (1) to stimulate and culture for at least 24 hours, and collecting the cells and supernatant;
the addition concentration of the absolute ethyl alcohol is 400 mmol/L-800 mmol/L.
2. The method for stimulating the maturation of dendritic cells according to claim 1, wherein said culture medium is 1640 complete medium.
3. A method of stimulating the maturation of dendritic cells comprising the steps of:
(1) obtaining dendritic cell precursor mononuclear cells (PBMC), and obtaining immature dendritic cells under the culture of a first culture medium;
(2) subjecting the cells obtained in step (1) to mature culture in a second culture medium for at least 24 hours to obtain dendritic cells;
the first culture medium is a culture medium containing GM-CSF and IL-4, and the second culture medium is absolute ethyl alcohol obtained by adding a ripener into the first culture medium;
the addition concentration of the absolute ethyl alcohol is 400 mmol/L-800 mmol/L.
4. The method for stimulating dendritic cell maturation according to claim 3, wherein the first medium is serum-free AIM-V medium.
5. The method for stimulating dendritic cell maturation according to claim 3, wherein the final concentration of GM-CSF is 800-1000U/ml and the final concentration of IL-4 is 800-1000U/ml.
6. The application of the absolute ethyl alcohol in preparing the ripener for stimulating the maturation of the dendritic cells is characterized in that the addition concentration of the absolute ethyl alcohol is 400 mmol/L-800 mmol/L.
CN202210338128.3A 2022-04-01 2022-04-01 A kind of method and medium for stimulating dendritic cell maturation Active CN114480277B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210338128.3A CN114480277B (en) 2022-04-01 2022-04-01 A kind of method and medium for stimulating dendritic cell maturation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210338128.3A CN114480277B (en) 2022-04-01 2022-04-01 A kind of method and medium for stimulating dendritic cell maturation

Publications (2)

Publication Number Publication Date
CN114480277A CN114480277A (en) 2022-05-13
CN114480277B true CN114480277B (en) 2022-07-22

Family

ID=81488364

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210338128.3A Active CN114480277B (en) 2022-04-01 2022-04-01 A kind of method and medium for stimulating dendritic cell maturation

Country Status (1)

Country Link
CN (1) CN114480277B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113881632B (en) * 2021-09-29 2023-09-29 四川省医学科学院·四川省人民医院 Cell culture medium for improving activity of DC cells and culture method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055597A1 (en) * 1997-06-06 1998-12-10 The Australian National University A method for culturing cells
CN101353679A (en) * 2008-09-22 2009-01-28 于荣敏 Bioconversion method using plant cell cultivation
CN101491362A (en) * 2009-02-17 2009-07-29 福州大学 Red tea fungus beverage produced by mixed culture fermentation of pure fungus
CN108118030A (en) * 2017-12-27 2018-06-05 重庆斯德姆生物技术有限公司 A kind of Dendritic Cells culture medium and cultural method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055597A1 (en) * 1997-06-06 1998-12-10 The Australian National University A method for culturing cells
CN101353679A (en) * 2008-09-22 2009-01-28 于荣敏 Bioconversion method using plant cell cultivation
CN101491362A (en) * 2009-02-17 2009-07-29 福州大学 Red tea fungus beverage produced by mixed culture fermentation of pure fungus
CN108118030A (en) * 2017-12-27 2018-06-05 重庆斯德姆生物技术有限公司 A kind of Dendritic Cells culture medium and cultural method

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction;Angela Dolganiuc et al.;《Alcohol Clin Exp Res》;20030630;全文 *
Alcohol Exposure Impairs Myeloid Dendritic Cell Function in Rhesus Macaques;Robert W Siggins;《Alcohol Clin Exp Res》;20090523;全文 *
Chronic and Acute Alcohol Exposure Prevents Monocyte-Derived Dendritic Cells from Differentiating and Maturing;B Buttari et al.;《Int J Immunopathol Pharmacol》;20081231;全文 *
Ethanol affects the generation,cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo;Audrey H.等;《Journal of Leukocyte Biology》;20060530;全文 *
Increased survival and decreased tumor size due to intratumoral injection of ethanol followed by administration of immature dendritic cells;Kumagi等;《International Journal of Oncology》;20031001;摘要、图3、图5 *
Inhibition of myeloid dendritic cell accessory cell function and induction of T cell anergy by alcohol correlates with decreased IL-12 production;Pranoti Mandrekar et al.;《J Immunol》;20040901;全文 *
维生素D3及其类似物对人树突状细胞表达CSF-1及其受体的作用;朱可健等;《中华微生物学和免疫学杂志》;20030930;全文 *

Also Published As

Publication number Publication date
CN114480277A (en) 2022-05-13

Similar Documents

Publication Publication Date Title
CN112410239B (en) Bacterial membrane vesicle and preparation method and application thereof
JP5856025B2 (en) Methods for obtaining monocytes or NK cells
CN114480277B (en) A kind of method and medium for stimulating dendritic cell maturation
CN109486763A (en) The Dendritic Cells cultural method of derived from peripheral blood
CN103405759B (en) Method for preparing tumor-specific DC vaccine by applying CD34+ cells of umbilical cord blood
CN109402057A (en) A kind of cultural method for the DC-CTL cell loading tumour cell excretion body
CN101173247A (en) A method for cultivating osteoclasts using mesenchymal stem cells combined with cytokines
CN106701680A (en) Combination factor for promoting maturity of dendritic cells and method for cultivating dendritic cells
CN107312751A (en) Special culture medium and culture method for inducing stable differentiation of mouse bone marrow cells into immature dendritic cells
WO2021123927A1 (en) Method of generation of lympho-myeloid niches
CN114149970B (en) Preparation method and application of peripheral blood hematopoietic stem cell-derived sensitized dendritic cells
CN108034634B (en) Method for separating endometrial mesenchymal stem cells from menstrual blood
CN107574149B (en) Maturation promoting method of dendritic cells and application thereof
CN113564115B (en) High-expansion DC-CIK cell, and preparation and application thereof
CN113801849B (en) Human breast benign phylliform tumor cell strain BPT-0526 and application thereof
CN111378620A (en) Culture method for inducing stable differentiation of bone marrow-derived dendritic cells into mature dendritic cells
WO2022061811A1 (en) Pharmaceutical composition, and preparation method therefor and application thereof
CN112111453A (en) A kind of immune cell culture system optimization method and activity detection method
CN102925412A (en) Method for preparing tumor specific antigen sensitized DC
CN117736988B (en) Culture medium for inducing Tscm cells, culture method and application thereof
CN105219727A (en) A kind of test kit for activating colorectal cancer specific immune response
CN109355260A (en) The Dendritic Cells cultural method in placental blood source
US20230405111A1 (en) Ebv-targeted allogeneic b cell vaccine and preparation method therefor
CN117701500B (en) Culture method and application of mesenchymal stem cells
CN107988157B (en) A kind of dendritic cell induction medium and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20250120

Address after: 100071 No. 8, xitoutiao, youanmenwai, Fengtai District, Beijing

Patentee after: Beijing Youan Hospital, Capital Medical University

Country or region after: China

Patentee after: Beijing Institute of liver diseases

Address before: 8 xitoutiao, youanmenwai, Fengtai District, Beijing 100069

Patentee before: Beijing Youan Hospital, Capital Medical University

Country or region before: China

TR01 Transfer of patent right